ScholarLens Back to search
2017•The Brown University Child and Adolescent Behavior LetterRequires access

Only 1 in 4 teens/young adults with OUDs get naltrexone or buprenorphine: Study

Alison Knopf

Open publisher page 0 citations

Abstract

While buprenorphine and naltrexone are both used for adolescents and young adults with opioid use disorder (OUD), the extent of such use has not been studied on a national basis, until the publication in JAMA Pediatrics in July of a study by Scott E. Hadland, M.D., and colleagues.

About this research paper

What this paper is about

While buprenorphine and naltrexone are both used for adolescents and young adults with opioid use disorder (OUD), the extent of such use has not been studied on a national basis, until the publication in JAMA Pediatrics in July of a study by Scott E. Hadland, M.D., and colleagues.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

While buprenorphine and naltrexone are both used for adolescents and young adults with opioid use disorder (OUD), the extent of such use has not been studied on a national basis, until the publication in JAMA Pediatrics in July of a study by Scott E. Hadland, M.D., and colleagues.

Key concepts: Naltrexone, Buprenorphine, Opioid use disorder, Medicine, Opioid, Psychiatry, Psychology, Internal medicine

Related papers

Related paper 1Related paper 2
Back to paper searchBrowse research topicsOriginal source
Only 1 in 4 teens/young adults with OUDs get naltrexone or buprenorphine: Study — Research Paper | ScholarLens